Characterization of the novel HLA-DQA1*05:14 allele by sequencing-based typing.

Alleles HLA-DQ alpha-Chains / genetics Histocompatibility Testing Humans Point Mutation Sequence Analysis, DNA
HLA HLA-DQA1*05:14 novel allele sequencing-based typing

Journal

HLA
ISSN: 2059-2310
Titre abrégé: HLA
Pays: England
ID NLM: 101675570

Informations de publication

Date de publication:
04 2019
Historique:
received: 01 02 2019
accepted: 06 02 2019
pubmed: 9 2 2019
medline: 14 5 2020
entrez: 9 2 2019
Statut: ppublish

Résumé

HLA-DQA1*05:14 differs from HLA-DQA1*05:05:01:01 by one nucleotide substitution at codon 90 in exon 3.

Identifiants

DOI: 10.1111/tan.13484 PMID: 30734536
pubmed: 30734536
doi: 10.1111/tan.13484
doi:

Substances chimiques

HLA-DQ alpha-Chains 0
HLA-DQA1 antigen 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

241-243

Informations de copyright

© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Auteurs

Marine Cargou (M)

CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France.
UMR CNRS 5164 Immunoconcept, Université de Bordeaux, Bordeaux, France.

Marco Andreani (M)

Laboratorio d'Immunogenetica dei Trapianti, IRCCS Ospedale Pediatrico Bambino Gesù, Roma, Italy.

Maria Troiano (M)

Laboratorio d'Immunogenetica dei Trapianti, IRCCS Ospedale Pediatrico Bambino Gesù, Roma, Italy.

Gwendaline Guidicelli (G)

CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France.

Jonathan Visentin (J)

CHU de Bordeaux, Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, Bordeaux, France.
UMR CNRS 5164 Immunoconcept, Université de Bordeaux, Bordeaux, France.
ORCID: 0000-0003-3795-8979

Articles similaires

Comprehensive comparative analysis and development of molecular markers for Lasianthus species based on complete chloroplast genome sequences.

Yue Zhang, Meifang Song, Deying Tang et al.
1.00
Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH

questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Génome › Composants de génome › Gènes › Allèles › Characterization of the novel HLA-DQA1*05:14...
questionsmedicales.fr › Facteurs biologiques › Antigènes › Isoantigènes › Antigènes d'histocompatibilité › Antigènes HLA › Antigènes HLA-D › Antigènes HLA-DQ › Chaines alpha des antigènes HLA-DQ › Characterization of the novel HLA-DQA1*05:14...
questionsmedicales.fr › Techniques d'investigation › Techniques immunologiques › Tests immunologiques › Test d'histocompatibilité › Characterization of the novel HLA-DQA1*05:14...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Characterization of the novel HLA-DQA1*05:14...
questionsmedicales.fr › Phénomènes génétiques › Variation génétique › Mutation › Mutation ponctuelle › Characterization of the novel HLA-DQA1*05:14...
questionsmedicales.fr › Techniques d'investigation › Techniques génétiques › Analyse de séquence › Analyse de séquence d'ADN › Characterization of the novel HLA-DQA1*05:14...